Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,009 | 48,737 | 58,181 | 38,184 | 46,227 |
| Marketable Securities | 22,038 | N/A | N/A | N/A | N/A |
| TOTAL | $57,189 | $50,314 | $59,986 | $39,036 | $46,926 |
| Non-Current Assets | |||||
| PPE Net | 327 | 316 | 306 | 328 | 224 |
| Intangibles | 120 | 120 | 0 | 0 | 0 |
| Other Non-Current Assets | 189 | 178 | 178 | 178 | 178 |
| TOTAL | $636 | $614 | $484 | $506 | $402 |
| Total Assets | $57,825 | $50,928 | $60,470 | $39,542 | $47,328 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,422 | 2,770 | 1,986 | 1,487 | 2,448 |
| Accrued Expenses | 2,675 | 1,849 | 1,531 | 1,895 | 1,049 |
| TOTAL | $5,097 | $4,619 | $3,517 | $3,382 | $3,497 |
| Non-Current Liabilities | |||||
| TOTAL | $77 | $65 | $67 | $68 | $54 |
| Total Liabilities | $5,174 | $4,684 | $3,584 | $3,450 | $3,551 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,832 | 18,830 | 16,138 | 16,138 | 10,772 |
| Common Shares | 19 | 16 | 16 | 11 | 11 |
| Retained earnings | -89,038 | -75,788 | -64,025 | -54,344 | -45,355 |
| Other shareholders' equity | 17 | 6 | 5 | 2 | 1 |
| TOTAL | $52,651 | $46,244 | $56,886 | $36,092 | $43,777 |
| Total Liabilities And Equity | $57,825 | $50,928 | $60,470 | $39,542 | $47,328 |